Motor effects of buspirone: Relationship with dopamine and serotonin in the striatum

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 12, 2005, Pages 753-756

  Shireen, Erum ^a   Haleem, Darakhshan J ^b  

^a PCSIR LABORATORIES COMPLEX   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Buspirone; Dopamine metabolism; Extrapyramidal effects; Serotonin metabolism

Indexed keywords

BUSPIRONE; DOPAMINE; SEROTONIN; SEROTONIN AGONIST;

ANIMAL; ARTICLE; BASAL GANGLION; DOSE RESPONSE; DRUG EFFECT; MALE; METABOLISM; MOTOR ACTIVITY; RAT; WISTAR RAT;

ANIMALS; BASAL GANGLIA; BUSPIRONE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS;

EID: 33646839323     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Temple DL Jr, Yevich JP, New JS. Buspirone: chemical profile of a new class of anxioselective agents. J Clin Psychiatry 1982; 43(12 pt2): 4-10.
2. Sathananthan GL, Sanghvi I, Phillips N, Gershon S. MJ 9022: correlation between neuroleptic potential and stereotypy. Curr Ther Res Clin Exp 1975; 18: 701-5.
3. Sharma RP, Shapiro LE. The 5-HT-1A receptor system: possible implications for schizophrenia negative symptomatology. Psychiatr Ann 1996; 26: 88-92.
4. Tunnicliff GB. Molecular basis of buspirone anxiolytic action. Pharmacol Toxicol 1991; 69: 149-56.
5. Cervo L, Munoz C, Bertaglia A, Samanin RB. Alnespirone and buspirone have anxiolytic-like effects in a conflict procedure in rats by stimulating 5-HT-1A receptors. Behav Pharmacol 2000; 11: 153-60.
6. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ. Buspirone modulates basal and fluoxetine stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin-1A receptors and blockade of alpha-2 adrenergic receptors underlie its actions. Neuroscience 1999; 93: 1251-62.
7. Haleem DJ, Shireen E, Haleem MA. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1323-9.
8. Haleem DJ, Khan NH. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 645-51.
9. Tada K, Kasamo K, Ueda N, Suzuki T, Kojima T, Ishikawa K. Anxiolytic 5-hydroxytryptonine-1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single unit study in unanesthetized, unrestrained rats. J Pharmacol Exp Ther 1999; 288: 843-8.
10. Freo U, Pietrini P, Pizzolato G, Furey-Kurkjian M, Merico A, Ruggero S, et al. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats. Brain Res 1995; 677: 213-20.
11. Schreiber R, DeVry J. 5-HT-1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of actions? Prog Neuropsychopharmacol Biol Psychiatry 1987; 17: 87-104.
12. Glitz DA, Pohl RB. 5-HT-1A partial agonists: what is their future? Drugs 1987; 41: 11-8.
13. Kitamura Y, Nagatani T, Watanabe TB. Buspirone enhances head twitch behavior in mice. Eur J Pharmacol 1994; 253: 297-301.
14. Grabowska M, Antikeiwicz L, Maj J, Michaluk J. Apomorphine and central serotonin neurons. Pol J Pharmacol 1973; 25: 29-39.
15. Baldessarini RJ, Amartruda TT, Griffith FF, Gerson S. Differential effects of serotonin on turning and stereotypy induced by apomorphine. Brain Res 1975; 93: 158-63.
16. Gustafsson B, Christensen EB. Amperozide, a new putatively antipsychotic drug with a limbic mode of action on DA mediated behavior. Pharmacol Toxicol 1987; 26: 71-4.
17. Conceicao IM, Frussa-Filho R. Effects of a single administration of buspirone on catalepsy, yawning and stereotypy in rats. Braz J Med Biol Res 1993; 261: 71-4.
18. Pruus K, Skrebuhhova-Malmros T, Rudisaar R, Matto V, Allikmet L. 5-HT-1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behavior in adult male Wistar rats. J Phsiol Pharmacol 2000; 51(4 pt 2): 833-46.
19. Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS, et al. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine and on tests related to extrapyramidal functions in rats. Med Sci Monit 2002; 8: BR 354-61.
20. Cole RJ, Rodgers RJ. Ethological evaluation of the effects acute and chronic buspirone treatment in the murine elevated plus maze test: comparison with haloperidol. Psychopharmacology 1994; 114: 288-96.
21. Ahlenius S, Hillegaart V, Salmi P, Wijkstrom A. Effects of 5-HT-1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis. Pharmacol Toxicol 1993; 72: 398-406.
22. Liang J, Wang X, Lu Y, Liu R, Zhang Q, Sun H, et al. Effects of antidepressants on the exploration, spontaneous motor activity and isolation induced aggressiveness in mice. Beijing Da Xa Xue Bao 2003; 35: 54-60.
23. Mignon L, Wolf WAB. Postsynaptic 5-HT-1A receptors mediate an increase in locomotor activity in the monoamines depleted rats. Psychopharmacology 2002; 163: 85-94.
24. Wadenberg ML, Young KA, Richter JT, Hicks PB. Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat. Neuropharmacology 1999; 38: 151-6.
25. Mercuri NB, Calabresi P, Bernardi GB. The electrophysiological action of dopamine and dopaminergic drugs on neurons of substantia nigra pars compacta and ventral tegmental area. Life Sci 1992; 51: 711-8.
26. Bischoff S, Baumann P, Krauss J, Maitre L, Vassout A, Storni A, et al. CGP 25454, a novel and selective presynaptic dopamine autoreceptor antagonist. Naunyn Schmiedbergs Arch Pharmacol 1994; 350: 230-8.
27. Westerink BIIG. Sequence and significance of dopamine metabolism in the rat brain. Neurosci Int 1985; 7: 221-7.
28. Haleem DJ. Attenuation of 8-OH-DPAT-induced decreases in 5-HT synthesis in brain regions of rats adapted to a repeated stress schedule. Stress 1999; 3: 123-9.
29. Jaskiw GE, Collins KA, Pehck EA Yamamoto BK. Tyrosine augments acute clozapine but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rats. an in vivo micro dialysis study. Neuropsychopharmacology 2001; 25: 149-56.
30. Riblet LA, Taylor DP, Eison MS. Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 1987; 43(12 pt 2): 11-8.
31. Millan MJ, Audinot V, Brocco M. S 16924; a pyrrolidine substituted benzodioxane with higher affinity at 5-HT-1A /2A/2C than D-2 receptors and an atypical antipsychotic profile in the rat. Br J Pharmacol 1995; 114(suppl): 156.